In a large transcriptomic dataset of GEP of 680 DLBCL patients that were treated with R-CHOP (Supplementary Tables 1 and 2), the OS of patients with high SLAMF7 expression did not differ from that of patients with low expression of SLAMF7 (Fig. 4a, p = 0.2). The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.